Skip to content
10-Q

Quarterly Report

PROTECT PHARMACEUTICAL Corp

0001493152-19-001537

← back to feed
Filed
Feb 7, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jun 30, 2017 1.11M sh
Stockholders Equity Q2 2017 · Jun 30, 2017 −$136.56K
Stockholders Equity Q2 2017 · Dec 31, 2016 −$20.83K
Current Liabilities Q2 2017 · Jun 30, 2017 $36.23K
Current Liabilities Q2 2017 · Dec 31, 2016 $20.83K
Total Liabilities Q2 2017 · Jun 30, 2017 $136.56K
Total Liabilities Q2 2017 · Dec 31, 2016 $20.83K
Total Assets Q2 2017 · Jun 30, 2017 $0
Total Assets Q2 2017 · Dec 31, 2016 $0
Operating Cash Flow restated Q2 2017 · Jun 30, 2016 −$8.56K
Sga Expense Q2 2017 · Jun 30, 2016 $103
Sga Expense Q2 2017 · Jun 30, 2016 $195
Net Income Q2 2017 · Jun 30, 2016 −$10.46K
Net Income Q2 2017 · Jun 30, 2016 −$14.13K
Operating Income Q2 2017 · Jun 30, 2016 −$10.46K
Operating Income Q2 2017 · Jun 30, 2016 −$14.13K